Skip to main content
Skip to main menu
UF Health
University of Florida
Powell Center
for
Rare Disease Research and Therapy
Department
of
Pediatrics
in
the
College
of
Medicine
Support our Mission
Open Search
Open Main Menu
Main Navigation
Home
About Us
Show submenu for About Us
About Us
Overview
Meet the Director
Publications
Gallery
Helpful Links
Clinical Research Sponsors
Patient Organizations and Foundations
Additional Caregiver Resources
Rare Disease Podcasts
Navigating Gainesville
Show submenu for Navigating Gainesville
Navigating Gainesville
Overview
Air Travel
Accessible Transport Rentals
Overnight Accommodations
Dining Experience
Fun Around Town
Fun Around Florida
Clinical Research Center
Show submenu for Clinical Research Center
Clinical Research Center
Overview
Research Team
Research Space
Clinical Trials
Amyotrophic Lateral Sclerosis
Barth Syndrome
Becker Muscular Dystrophy
Duchenne Muscular Dystrophy
Friedreich's Ataxia
Mucopolysaccharidosis I
Myotubular Myopathy
Neuromuscular Diseases
Pompe Disease
Neuromuscular Clinic
Show submenu for Neuromuscular Clinic
Neuromuscular Clinic
Overview
Clinical Team
Care Center Space
Conditions We Treat
Commercial Treatments
Emflaza (Deflazacort)
Evrysdi (risdiplam)
Lumizyme (alglucosidase alfa)
Spinraza (Nusinersen)
EXONDYS 51 (Eteplirsen)
VYONDYS 53 (Golodirsen)
Zolgensma (Onasemnogene abeparvovec)
Diagnostic Testing
Patients & Families
Preparing For Your Appointment
MyUFHealth (MyChart)
Genetic Testing
Applying for Disability
COVID-19
Influenza (Flu) Season
Referrals
Research
News
Contact Us
All Posts
Archive
All Posts
Smith receives James Dunleavy Distinguished Service Award
February 16, 2021
Santhera Shares Community Update on Phase 2b Trial for Vamorolone
February 1, 2021
Provention Bio Announces Key Findings from Pre-clinical Proof-of-concept Study
January 28, 2021
Sarepta Therapeutics Announces Results for Part 1 of Study Evaluating SRP-9001
January 7, 2021
Pfizer doses the first participant in the Phase 3 CIFFREO study
January 7, 2021
REGENXBIO Announces New Gene Therapy Program for Duchenne
January 5, 2021
Sarepta Therapeutics Announces Positive Clinical Results from MOMENTUM
December 7, 2020
Denison Magazine: The Idea Guy
November 2, 2020
Antisense Therapeutics Receives FDA Orphan Drug Designation for ATL1102
November 2, 2020
Antisense Therapeutics Receives US FDA Orphan Drug Designation for ATL1102
October 26, 2020
First
Prev
1
2
3
4
5
Next
Last
